Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination
Clin Rheumatol
.
2022 May;41(5):1611-1612.
doi: 10.1007/s10067-021-05948-5.
Epub 2021 Oct 2.
Authors
Ian Liang
1
,
Sanjay Swaminathan
1
2
3
4
5
,
Adrian Y S Lee
6
7
8
Affiliations
1
Department of Clinical Immunology, Westmead Hospital, Westmead, NSW, Australia.
2
Department of Immunopathology, NSW Health Pathology & ICPMR, Westmead Hospital, Westmead, NSW, Australia.
3
Sydney Medical School, Westmead Hospital, Westmead, NSW, Australia.
4
Centre for Allergy and Immunology Research, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
5
School of Medicine, Western Sydney University, Westmead, NSW, Australia.
6
Department of Clinical Immunology, Westmead Hospital, Westmead, NSW, Australia. adrian.lee1@health.nsw.gov.au.
7
Department of Immunopathology, NSW Health Pathology & ICPMR, Westmead Hospital, Westmead, NSW, Australia. adrian.lee1@health.nsw.gov.au.
8
Sydney Medical School, Westmead Hospital, Westmead, NSW, Australia. adrian.lee1@health.nsw.gov.au.
PMID:
34599716
PMCID:
PMC8487223
DOI:
10.1007/s10067-021-05948-5
No abstract available
Publication types
Editorial
MeSH terms
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination / adverse effects
Vasculitis* / etiology